EP1082122A4 - Isoflavonoids for treatment and prevention of migraine headaches - Google Patents

Isoflavonoids for treatment and prevention of migraine headaches

Info

Publication number
EP1082122A4
EP1082122A4 EP99925828A EP99925828A EP1082122A4 EP 1082122 A4 EP1082122 A4 EP 1082122A4 EP 99925828 A EP99925828 A EP 99925828A EP 99925828 A EP99925828 A EP 99925828A EP 1082122 A4 EP1082122 A4 EP 1082122A4
Authority
EP
European Patent Office
Prior art keywords
isoflavonoids
prevention
treatment
migraine headaches
headaches
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99925828A
Other languages
German (de)
French (fr)
Other versions
EP1082122A1 (en
Inventor
Sherwood L Gorbach
Barry R Goldin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1082122A1 publication Critical patent/EP1082122A1/en
Publication of EP1082122A4 publication Critical patent/EP1082122A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99925828A 1998-05-27 1999-05-25 Isoflavonoids for treatment and prevention of migraine headaches Withdrawn EP1082122A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85480 1993-06-21
US8548098A 1998-05-27 1998-05-27
PCT/US1999/011532 WO1999061028A1 (en) 1998-05-27 1999-05-25 Isoflavonoids for treatment and prevention of migraine headaches

Publications (2)

Publication Number Publication Date
EP1082122A1 EP1082122A1 (en) 2001-03-14
EP1082122A4 true EP1082122A4 (en) 2003-04-09

Family

ID=22191888

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99925828A Withdrawn EP1082122A4 (en) 1998-05-27 1999-05-25 Isoflavonoids for treatment and prevention of migraine headaches

Country Status (4)

Country Link
EP (1) EP1082122A4 (en)
AU (1) AU4204099A (en)
CA (1) CA2333556A1 (en)
WO (1) WO1999061028A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132084A1 (en) * 2000-03-06 2001-09-12 Docteur Nature Srl Transdermal device for the slow release of soybean derived vegetable estrogens
EP1401413B1 (en) 2001-06-29 2006-11-22 AB Science Use of tyrosine kinase inhibitions for treating allergic diseases
PT1401416E (en) 2001-06-29 2007-02-28 Ab Science Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd)
CA2452368A1 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
WO2003002108A2 (en) 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
ES2269994T3 (en) * 2002-02-27 2007-04-01 Ab Science USE OF INHIBITORS OF THE TYROSINE KINASE, FOR THE TREATMENT OF CNS DISORDERS.
WO2004039327A2 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
EP1545206B1 (en) 2002-07-24 2020-03-04 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
CN1988882A (en) * 2004-07-23 2007-06-27 宝洁公司 Substrate based skin care device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008503A1 (en) * 1996-08-30 1998-03-05 Novogen Research Pty. Ltd. Therapeutic methods and compositions involving isoflavones
EP0906761A2 (en) * 1997-10-02 1999-04-07 Archer-Daniels-Midland Company Method of preparing and using phytochemicals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008503A1 (en) * 1996-08-30 1998-03-05 Novogen Research Pty. Ltd. Therapeutic methods and compositions involving isoflavones
EP0906761A2 (en) * 1997-10-02 1999-04-07 Archer-Daniels-Midland Company Method of preparing and using phytochemicals

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HIRAKURA K ET AL: "Phenolic glucosides from the root of Pueraria lobata", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 46, no. 5, November 1997 (1997-11-01), pages 921 - 928, XP004293503, ISSN: 0031-9422 *
KITAZONO TAKANARI ET AL: "Role of tyrosine kinase in serotonin-induced constriction of the basilar artery in vivo.", STROKE, vol. 29, no. 2, February 1998 (1998-02-01), pages 494 - 498, XP002229783, ISSN: 0039-2499 *
See also references of WO9961028A1 *

Also Published As

Publication number Publication date
EP1082122A1 (en) 2001-03-14
WO1999061028A1 (en) 1999-12-02
AU4204099A (en) 1999-12-13
CA2333556A1 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
EP0957919A4 (en) Analgesic composition for treatment of migraine headaches
EP1054652A4 (en) Device and method for treatment of headaches
HK1040944A1 (en) Methods and compositions for the prevention and treatment of anemia
PL338082A1 (en) Methods of treating obesity
EP1077704A4 (en) Combination therapy for treatment of depression
GB0011925D0 (en) Composition and method for preventing or alleviating migraine headaches
AP2001002080A0 (en) Pilveriser and method of pulverising
EP1239855A4 (en) Method for the prevention and/or treatment of atherosclerosis
EP1082122A4 (en) Isoflavonoids for treatment and prevention of migraine headaches
HUP0002509A2 (en) Combination composition for treatment of migraine
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
PL345803A1 (en) Prevention of migraine recurrence
EP0983958A4 (en) Treadboard device of man-conveyer and man-conveyer
ZA981781B (en) The use of levobupivacaine in treating migraine
IL143212A0 (en) Compositions and methods for the treatment of tumor
HU0002508D0 (en) Combination therapy for treatment of migraine
HUP0102995A3 (en) Agents and method for the protective treatment of wood
AU2002232457A1 (en) Method of treating and preventing migraine headaches
AU2599399A (en) Method of treating migraine
HUP9900436A3 (en) Installation and method for the treatment of wine-production efilvents
IL138484A0 (en) Treatment of panic attacks
GB9926559D0 (en) Treatment of cellulite
SI1500396T1 (en) Reboxetine for treating migraine headaches
GB0021287D0 (en) Composition and method for the treatment of cancers
LT98032A (en) Device for treatment and conditioning of water

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030224

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031203